Central Nervous System Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Central Nervous System Agents
Volume 20, 3 Issues, 2020
ISSN: 1875-6166 (Online)
ISSN: 1871-5249 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal
ISSN: 1875-6166 (Online)
ISSN: 1871-5249 (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Central Nervous System Agents in Medicinal Chemistry , Volume 20 - Number 1
Biography Open Access
Preface Open Access
Research Article Open Access
Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
, 20(1): 3 - 12Saganuwan A. Saganuwan*
DOI: 10.2174/1871524919666190621160323
Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
Research Article
An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice
, 20(1): 13 - 25Anthony T. Olofinnade, Tolulope M. Onaolapo, Samad Oladimeji, Adetunji M. Fatoki, Covenant I. Balogun, Adejoke Y. Onaolapo* and Olakunle J. Onaolapo
DOI: 10.2174/1871524920666200120142508
An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice
Research Article
Electronegativity in Substituted-4(H)-quinazolinones Causes Anxiolysis without a Sedative-hypnotic Adverse Reaction in Female Wistar Rats
, 20(1): 26 - 40Shweta Mishra, Debashree Das, Adarsh Sahu, Ekta Verma, Shailendra Patil, Ram Kishore Agarwal and Asmita Gajbhiye*
DOI: 10.2174/1871524920666191220112545
Electronegativity in Substituted-4(H)-quinazolinones Causes Anxiolysis without a Sedative-hypnotic Adverse Reaction in Female Wistar Rats
Research Article
Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity
, 20(1): 41 - 48Krishan K. Verma*, Umesh K. Singh and Jainendra Jain
DOI: 10.2174/1871524919666191209103003
Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity
Research Article Open Access
An Assessment of the Effects of Azodicarbonamide-containing Diet on Neurobehaviour, Brain Antioxidant Status and Membrane Lipid Peroxidation Status in Rats
, 20(1): 49 - 57Anthony T. Olofinnade, Adegboyega Adeyeba, Adejoke Y. Onaolapo and Olakunle J. Onaolapo*
DOI: 10.2174/1871524919666191104154009
An Assessment of the Effects of Azodicarbonamide-containing Diet on Neurobehaviour, Brain Antioxidant Status and Membrane Lipid Peroxidation Status in Rats
Research Article Open Access
The Computational Analysis Conducted on miRNA Target Sites in Association with SNPs at 3’UTR of ADHD-implicated Genes
, 20(1): 58 - 75Adel Abdi, Mina Zafarpiran and Zeinab S. Farsani*
DOI: 10.2174/1871524919666191014104843
The Computational Analysis Conducted on miRNA Target Sites in Association with SNPs at 3’UTR of ADHD-implicated Genes
Co-Editors
G. Aliev
"GALLY" International Biomedical Research Consulting LLC
San Antonio, TX
(USA)
Biography
"GALLY" International Biomedical Research Consulting LLC
San Antonio, TX
Biography
Biography of G. Aliev
Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, as a Professor and as a Leading Scientist , Institute of Physiologically Active Compounds. Russian Academy of Sciences.
He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy.
G.S. Hamilton
Biopharma Research Leader, Organic and Medical Chemist, Registered US Patent Agent
Catonsville, MD
(USA)
Biography
Biopharma Research Leader, Organic and Medical Chemist, Registered US Patent Agent
Catonsville, MD
Biography
Biography of G.S. Hamilton
Dr. Gregory received his bachelor’s and PhD degrees in chemistry from the University of Virginia and worked on the synthesis of complex indole alkaloids. In 1988, he joined Nova Pharmaceuticals Inc. He became the Vice President of Chemistry in 1997.
In 2002, as Vice-President, he joined Artesian Therapeutics in Gaithersburg and designed and patented an IND candidate in a year.
In 2005, he joined MGI PHARMA, as head of the medicinal chemistry. In 2007, he became the Senior Director of Intellectual Property, and in 2008, he worked as senior member of IP group
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Central Nervous System Agents was launched in 2001 and later renamed in 2006 as Central Nervous System Agents in Medicinal Chemistry.
Scopus CiteScore Metrics: 1.34
Advertisement
Webmaster Contact: info@benthamscience.net